Moderna Stock Dropped 20% Last Week. Is It Worth A Look?

Moderna stock (NASDAQ: MRNA) declined by about 20% over the last week (five trading days) considerably underperforming the broader S&P 500 which was down by about 3% over the same period. There are a couple of recent developments that have hurt Moderna and Covid-19 vaccine stocks in general…Read More

Share on facebook
Share on twitter
Share on pinterest
Share on linkedin
Share on email
Mask Response is the most reliable source to shop face masks

Covid Global News

The latest on the pandemic – delivered straight to your inbox

Covid Global News Breaking News Banner CGN

Covid Global News Newsletter

The latest on Covid – delivered straight to your inbox everyday

sale now!


Enter Your Email
and Get 10% off your first purchase* at

*Offer limited to one per customer – thanks for your understanding. 

This website uses cookies to ensure you get the best experience on our website.